These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2508325)

  • 1. Transmission of non-A, non-B hepatitis by pH4-treated intravenous immunoglobulin.
    Williams PE; Yap PL; Gillon J; Crawford RJ; Urbaniak SJ; Galea G
    Vox Sang; 1989; 57(1):15-8. PubMed ID: 2508325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum ALT levels in patients with primary hypogammaglobulinaemia receiving replacement therapy with intravenous immunoglobulin or fresh frozen plasma.
    Leen CL; Yap PL; Neill G; McClelland DB; Westwood A
    Vox Sang; 1986; 50(1):26-32. PubMed ID: 3082075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance of Scottish National Blood Transfusion Service intravenous immunoglobulin in patients with primary hypogammaglobulinaemia: report of 1235 infusions.
    Leen CL; Yap PL; Williams PE; McClelland DB
    Scott Med J; 1988 Aug; 33(4):303-6. PubMed ID: 3187500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced risk of non-A, non-B hepatitis after a first exposure to 'wet heated' factor VIII concentrate.
    Kernoff PB; Miller EJ; Savidge GF; Machin SJ; Dewar MS; Preston FE
    Br J Haematol; 1987 Oct; 67(2):207-11. PubMed ID: 3118932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the safety of three intravenous immunoglobulin preparations in patients with primary hypogammaglobulinaemia.
    Yap PL; McClelland DB
    J Infect; 1986 Jan; 12(1):5-10. PubMed ID: 3082994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute unidentified hepatitis in a hypogammaglobulinaemic patient on intravenous gammaglobulin successfully treated with interferon.
    Lockner D; Bratt G; Lindborg A; Törnebohm E
    Acta Med Scand; 1987; 221(4):413-5. PubMed ID: 3111178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin prophylaxis causing liver damage in 16 of 77 patients with hypogammaglobulinemia or IgG subclass deficiency.
    Björkander J; Cunningham-Rundles C; Lundin P; Olsson R; Söderström R; Hanson LA
    Am J Med; 1988 Jan; 84(1):107-11. PubMed ID: 3122562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase of serum immunoglobulin level into the normal range in primary hypogammaglobulinaemia by dosage individualization of intravenous immunoglobulin.
    Leen CL; Yap PL; McClelland DB
    Vox Sang; 1986; 51(4):278-86. PubMed ID: 3798863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin.
    Lever AM; Webster AD; Brown D; Thomas HC
    Lancet; 1984 Nov; 2(8411):1062-4. PubMed ID: 6150140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfusion transmitted non-A, non-B hepatitis.
    Iwarson S
    Acta Anaesthesiol Scand Suppl; 1988; 89():13-5. PubMed ID: 3147565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic non-A, non-B hepatitis in pregnancy: outcome and possible transmission to the offspring.
    Wejstål R; Norkrans G
    Scand J Infect Dis; 1989; 21(5):485-90. PubMed ID: 2511624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dry-heating of coagulation factor concentrates at 80 degrees C for 72 hours on transmission of non-A, non-B hepatitis. Study Group of the UK Haemophilia Centre Directors on Surveillance of Virus Transmission by Concentrates.
    Lancet; 1988 Oct; 2(8615):814-6. PubMed ID: 2902265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective study on the hepatitis safety of intravenous immunoglobulin, pH 4.25.
    Rousell RH; Budinger MD; Pirofsky B; Schiff RI
    Vox Sang; 1991; 60(2):65-8. PubMed ID: 1709545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis.
    Miyamura T; Saito I; Katayama T; Kikuchi S; Tateda A; Houghton M; Choo QL; Kuo G
    Proc Natl Acad Sci U S A; 1990 Feb; 87(3):983-7. PubMed ID: 2105505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin preparation: safe from virus transmission?
    Uemura Y; Yokoyama K; Nishida M; Suyama T
    Vox Sang; 1989; 57(1):1-3. PubMed ID: 2508323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission of non-A, non-B hepatitis by pH4-treated immunoglobulin.
    Morgenthaler JJ; Heiniger HJ
    Vox Sang; 1990; 58(4):309-10. PubMed ID: 2119088
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-A, non-B hepatitis transmission by intravenous immunoglobulin.
    Williams PE; Yap PL; Gillon J; Crawford RJ; Galea G; Cuthbertson B
    Lancet; 1988 Aug; 2(8609):501. PubMed ID: 2900414
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-A, non-B hepatitis after intravenous gammaglobulin.
    Weiland O; Mattsson L; Glaumann H
    Lancet; 1986 Apr; 1(8487):976-7. PubMed ID: 2871273
    [No Abstract]   [Full Text] [Related]  

  • 19. Non-A, non-B hepatitis from intravenous immunoglobulin.
    Lane RS
    Lancet; 1983 Oct; 2(8356):974-5. PubMed ID: 6138539
    [No Abstract]   [Full Text] [Related]  

  • 20. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.